[Photo] Jungnang-gu Begins Distribution of Oral COVID-19 Antiviral Medication to Home Treatment Patients
On the afternoon of the 14th, an employee from the Jungnang-gu Public Health Center is receiving the oral COVID-19 treatment drug 'Paxlovid' at a local designated pharmacy.
View original image[Asia Economy Reporter Park Jong-il] Jungnang-gu (Mayor Ryu Gyeong-gi) began delivering oral COVID-19 antiviral treatment (Paxlovid) to local home treatment patients starting from the afternoon of the 14th.
On the same day, the district completed delivery of the treatment to the home of a patient in their 60s receiving home treatment who had been prescribed the medication. Eligible patients are those undergoing home treatment or residing in residential treatment centers who have mild to moderate symptoms within 5 days of symptom onset, are aged 65 or older, or are immunocompromised.
Patients receive prescriptions through non-face-to-face consultations from local home treatment management medical institutions such as Green Hospital, Dongbu Jeil Hospital, and Seoul Medical Center, and then receive the medication along with medication guides and informational leaflets from public health center staff.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- The Distributor Asked...How Much Do You Really Know About the Nightlife Scene [ChwiYakGukga]①
- "Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
On the 12th, the district conducted a rehearsal for prescribing and delivering the treatment in collaboration with home treatment management medical institutions and designated pharmacies. After confirming the prescription, the district plans to ensure rapid delivery and monitor the patient's condition in real time.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.